Michael Gorton’s Recuro Health sees a bright future in home testing for blood sugar, heart health and more. “Texas said you shouldn’t treat a patient you can’t touch,” recalls Gorton. In the long run, new advances in remote patient monitoring and genetics will cut billions of dollars in costs out of the $3.6 trillion U.S. healthcare industry and help patients stay healthy longer. Such conditions could be caught early with advanced digital and genetic markers that assess a patient’s “trend lines” of biometric markers. “We want really simple gauges that keep people on trend lines,” that can be tested bi-annually with at-home testing kits.

Source: Forbes August 10, 2021 20:26 UTC